Exemestane: A milestone against breast cancer

Rapid advances in the treatment of breast cancer, especially in the form of hormone therapy have truly increased the hope of longer and better disease-free survival for these patients. Exemestane, a third generation aromatase inhibitor has been extensively evaluated in metastatic as well as adjuvant...

Full description

Bibliographic Details
Main Authors:	Shetty Y, Chakkarwar P, Acharya S, Rajadhyaksha V
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2007-01-01
Series:	Journal of Postgraduate Medicine
Subjects:	Aromatase inhibitors breast cancer hormonal therapy
Online Access:	http://www.jpgmonline.com/article.asp?issn=0022-3859;year=2007;volume=53;issue=2;spage=135;epage=138;aulast=Shetty

id	doaj-16bf1e7f8d29474b975405a5b788abc1
record_format	Article
spelling	doaj-16bf1e7f8d29474b975405a5b788abc12020-11-24T23:08:59ZengWolters Kluwer Medknow PublicationsJournal of Postgraduate Medicine0022-38590972-28232007-01-01532135138Exemestane: A milestone against breast cancerShetty YChakkarwar PAcharya SRajadhyaksha VRapid advances in the treatment of breast cancer, especially in the form of hormone therapy have truly increased the hope of longer and better disease-free survival for these patients. Exemestane, a third generation aromatase inhibitor has been extensively evaluated in metastatic as well as adjuvant therapy of breast cancer. It has also been evaluated for its safety profile, especially on bone and lipids. Exemestane provides hope to the patients with breast cancer both in early and metastatic disease. This review analyzes all the aspects of exemestane therapy.http://www.jpgmonline.com/article.asp?issn=0022-3859;year=2007;volume=53;issue=2;spage=135;epage=138;aulast=ShettyAromatase inhibitorsbreast cancerhormonal therapy
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Shetty Y Chakkarwar P Acharya S Rajadhyaksha V
spellingShingle	Shetty Y Chakkarwar P Acharya S Rajadhyaksha V Exemestane: A milestone against breast cancer Journal of Postgraduate Medicine Aromatase inhibitors breast cancer hormonal therapy
author_facet	Shetty Y Chakkarwar P Acharya S Rajadhyaksha V
author_sort	Shetty Y
title	Exemestane: A milestone against breast cancer
title_short	Exemestane: A milestone against breast cancer
title_full	Exemestane: A milestone against breast cancer
title_fullStr	Exemestane: A milestone against breast cancer
title_full_unstemmed	Exemestane: A milestone against breast cancer
title_sort	exemestane: a milestone against breast cancer
publisher	Wolters Kluwer Medknow Publications
series	Journal of Postgraduate Medicine
issn	0022-3859 0972-2823
publishDate	2007-01-01
description	Rapid advances in the treatment of breast cancer, especially in the form of hormone therapy have truly increased the hope of longer and better disease-free survival for these patients. Exemestane, a third generation aromatase inhibitor has been extensively evaluated in metastatic as well as adjuvant therapy of breast cancer. It has also been evaluated for its safety profile, especially on bone and lipids. Exemestane provides hope to the patients with breast cancer both in early and metastatic disease. This review analyzes all the aspects of exemestane therapy.
topic	Aromatase inhibitors breast cancer hormonal therapy
url	http://www.jpgmonline.com/article.asp?issn=0022-3859;year=2007;volume=53;issue=2;spage=135;epage=138;aulast=Shetty
work_keys_str_mv	AT shettyy exemestaneamilestoneagainstbreastcancer AT chakkarwarp exemestaneamilestoneagainstbreastcancer AT acharyas exemestaneamilestoneagainstbreastcancer AT rajadhyakshav exemestaneamilestoneagainstbreastcancer
_version_	1725612051207815168

Exemestane: A milestone against breast cancer

Similar Items